COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02436668
Brief Title: Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)

First Submitted : May 4, 2015
First Submitted that Met QC Criteria : May 6, 2015
First Posted : May 7, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : August 9, 2019
Last Update Posted : August 13, 2019